Instituto de Oncologia do Parana

Curitiba 80530-010

0 studies enrolling now · 1 studies all time

What they study most

Urothelial Cancer

Studies at this site

• A Study of Erdafitinib Compared With Vinflunine or Docetaxel or Pembrolizumab in Participants With Advanced Urothelial Cancer and Selected Fibroblast Growth Factor Receptor (FGFR) Gene Aberrations — Running, not enrolling